MB Rios

Statistics

Publications

Citations

496

H-Index

Active since

1992

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

MB Rios is an author at The University of Texas MD Anderson Cancer Center specializing in chemotherapy in hematologic malignancies, oncology, and chemotherapy.

Publications per year

1992–1995

Publications

Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase

Susan O’Brien, Hagop M. Kantarjian, M Keating et al. · Blood · 1995 · 182 citations · Full text

Medicine, Hematology, Pharmacology +8

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

HM Kantarjian, Miloslav Beran, Amy Ellis et al. · Blood · 1993 · 132 citations · Full text

Medicine, Oncology, Pharmacology +12

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

HM Kantarjian, Miloslav Beran, Amy Ellis et al. · Blood · 1993 · 94 citations · Full text

Medicine, Oncology, Pharmacology +12

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia

HM Kantarjian, EH Estey, S O'Brien et al. · Blood · 1992 · 54 citations · Full text

Medicine, Hematology, Oncology +12

Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia

Moshe Talpaz, C Hirsch-Ginsberg, Ruchi Pherwani et al. · Blood · 1995 · 34 citations · Full text

Life Sciences, Hematology, Oncology +15

1–5 of 5